| Nicholas G Ross, MD | |
|
81 Highland St, Salem Hospital, Salem, MA 01970-1559 | |
| (978) 354-3517 | |
| Not Available |
| Full Name | Nicholas G Ross |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 81 Highland St, Salem, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366489940 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 210360 (Massachusetts) | Primary |
| Entity Name | North Shore Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588606123 PECOS PAC ID: 3577467224 Enrollment ID: O20050429000668 |
News Archive
The US FDA has asked for a limit on the amount of acetaminophen in prescription pain medicines in an effort to reduce the risk of liver damage. The announcement yesterday asked manufacturers to limit combination drugs such as the opioids Percocet and Vicodin to 325 milligrams of acetaminophen per pill and asked them to carry a "black box" warning about potential liver failure. At present these combinations carry up to 750 milligrams of acetaminophen.
Idera Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that enrollment is open for a Phase 1/2 clinical trial of IMO-8400 in patients with Waldenström's macroglobulinemia, following acceptance of its Investigational New Drug application by the U.S. Food and Drug Administration.
Daiichi Sankyo Company, Limited, has announced that it has initiated its pivotal Phase III trial for DU-176b, an investigational oral Factor Xa inhibitor, in patients with atrial fibrillation. DU-176b is being developed solely by Daiichi Sankyo.
Scientists' picture of how a gene strongly linked to Alzheimer's disease harms the brain may have to be revised, researchers at Washington University School of Medicine in St. Louis have found. People with harmful forms of the APOE gene have up to 12 times the risk of developing Alzheimer's disease compared with those who have other variations of the gene.
Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body's immune response to a virus, can later interfere with the repair of lung tissue.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas G Ross, MD 27 Haskell St, Apt 2, Cambridge, MA 02140-1834 Ph: (978) 354-3517 | Nicholas G Ross, MD 81 Highland St, Salem Hospital, Salem, MA 01970-1559 Ph: (978) 354-3517 |
News Archive
The US FDA has asked for a limit on the amount of acetaminophen in prescription pain medicines in an effort to reduce the risk of liver damage. The announcement yesterday asked manufacturers to limit combination drugs such as the opioids Percocet and Vicodin to 325 milligrams of acetaminophen per pill and asked them to carry a "black box" warning about potential liver failure. At present these combinations carry up to 750 milligrams of acetaminophen.
Idera Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that enrollment is open for a Phase 1/2 clinical trial of IMO-8400 in patients with Waldenström's macroglobulinemia, following acceptance of its Investigational New Drug application by the U.S. Food and Drug Administration.
Daiichi Sankyo Company, Limited, has announced that it has initiated its pivotal Phase III trial for DU-176b, an investigational oral Factor Xa inhibitor, in patients with atrial fibrillation. DU-176b is being developed solely by Daiichi Sankyo.
Scientists' picture of how a gene strongly linked to Alzheimer's disease harms the brain may have to be revised, researchers at Washington University School of Medicine in St. Louis have found. People with harmful forms of the APOE gene have up to 12 times the risk of developing Alzheimer's disease compared with those who have other variations of the gene.
Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body's immune response to a virus, can later interfere with the repair of lung tissue.
› Verified 3 days ago
John A Michael, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 28 1/2 Broad St, Salem, MA 01970 Phone: 978-740-1878 | |
Dr. Lindsay K Fossett, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 81 Highland Ave, Salem Hospital Emergency Department, Salem, MA 01970 Phone: 978-354-3500 | |
Grace Taylor, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Dove Street, Salem, MA 01970 Phone: 978-741-1200 | |
Jenai E Beland Cohen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Salem Hospital, 81 Highland Avenue, Salem, MA 01970 Phone: 978-354-3500 | |
Thomas Edward Javery, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 35 Congress St, Salem, MA 01970 Phone: 678-825-7100 | |
Mohammed Saad Alkhafaji, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 81 Highland Ave, Salem, MA 01970 Phone: 978-741-1200 | |
Richard M Jackson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 81 Highland Ave, Salem, MA 01970 Phone: 978-741-1200 Fax: 978-740-4731 |